Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS
04:01pm, Tuesday, 04'th Feb 2025
THOUSAND OAKS, Calif. , Feb. 4, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable periods in 2023.
These Were the 5 Top-Performing Stocks in the Dow Jones Industrial Average in January 2025
02:10pm, Tuesday, 04'th Feb 2025
The Dow Jones Industrial Average got off to a solid start this year. The widely reported index, consisting of 30 large-cap stocks representing multiple sectors of the economy, gained 4.7% in the first
The Dow Jones Industrials Are Winning 2025: 4 Highest-Yielding Dogs of the Dow Are Steals
04:12pm, Monday, 03'rd Feb 2025
The Dow Jones industrial average (DJIA) is a price-weighted average of 30 blue-chip U.S.
Will These 5 Big Drug Stocks Surpass Q4 Earnings Forecasts?
12:20pm, Monday, 03'rd Feb 2025
Let's look at five pharma and drug companies, MRK PFE, LLY, AMGN and BMY, which are scheduled to release their fourth-quarter 2024 results later this week.
Are These 5 Biotech Stocks Set to Beat Q4 Earnings Estimates?
08:45am, Monday, 03'rd Feb 2025
Let us look at some biotech stocks, AMGN, CRSP, MRNA, SRPT and VRTX, which are poised to beat on fourth-quarter earnings.
AMGEN ANNOUNCES WEBCAST OF 2024 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS
06:30pm, Friday, 31'st Jan 2025
THOUSAND OAKS, Calif., Jan. 31, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its fourth quarter and full year 2024 financial results on Tuesday, February 4, 2025, after
Curious about Amgen (AMGN) Q4 Performance? Explore Wall Street Estimates for Key Metrics
10:21am, Friday, 31'st Jan 2025
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Amgen (AMGN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quar
4 Healthcare Stocks Poised to Crush Q4 Earnings Estimates
10:01am, Friday, 31'st Jan 2025
Rising patient volumes, technological advancements, rate hikes and other factors are likely to have benefited healthcare players during Q4. Companies like AMGN, COR, HUM and ARDT are likely to outperf
Here's Why Amgen (AMGN) is a Strong Momentum Stock
10:51am, Thursday, 30'th Jan 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Amgen Set to Report Q4 Earnings: Is a Beat in the Cards?
12:11pm, Wednesday, 29'th Jan 2025
Volume growth of AMGN's key drugs like Prolia, Repatha and Evenity is expected to have been partially offset by biosimilar/generic competition for mature drugs.
Here's Why Amgen (AMGN) is a Strong Value Stock
10:46am, Wednesday, 29'th Jan 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Amgen (AMGN) Stock Dips While Market Gains: Key Facts
06:56pm, Tuesday, 28'th Jan 2025
The latest trading day saw Amgen (AMGN) settling at $280.30, representing a -0.94% change from its previous close.
Amgen (AMGN) Reports Next Week: Wall Street Expects Earnings Growth
11:05am, Tuesday, 28'th Jan 2025
Amgen (AMGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Most-Watched Stock Amgen Inc. (AMGN) Worth Betting on Now?
10:01am, Monday, 27'th Jan 2025
Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.
5 Best CEFs This Month For Nearly 10% Yield (January 2025)
08:00am, Saturday, 25'th Jan 2025
For income investors, closed-end funds, or CEFs, remain an attractive investment class that covers various asset classes and promises high distributions and reasonable total returns. CEFs are generall
